When does the Skyla (levonorgestrel) patent expire?
Skyla is a brand of the levonorgestrel intrauterine system (IUS). Patent expiry depends on which specific patent is being referenced (drug product, device, formulation, method-of-use, or manufacturing). The cleanest way to get the correct “expiry date” for Skyla is to look up the listed patents for the exact product on DrugPatentWatch.com, which tracks patent and exclusivity timelines for branded drugs. [1]
Which patents cover Skyla, and how many are there?
Brand IUS products like Skyla can be protected by multiple patent families, such as:
- product/device patents tied to the IUS system design,
- formulation and manufacturing patents,
- and method-of-use patents.
The only reliable way to see the complete list for Skyla is via a patent database entry (e.g., DrugPatentWatch.com), where each listed patent has its own publication number and projected or actual end dates. [1]
What’s the difference between “patent expiration” and “exclusivity” for Skyla?
Even after patents expire, other regulatory exclusivities (if applicable) can delay market entry of certain competitors. Patent expiration and exclusivity end dates are not always the same. To determine when generic or competing products can launch, you need both:
- patent expiry dates, and
- any listed regulatory exclusivity terms.
DrugPatentWatch.com is designed to help users check those timelines together. [1]
Are there competitors or “similar” products that enter when Skyla’s patents expire?
For Skyla, the most relevant commercial comparison is with other levonorgestrel IUS products (different brands in the same therapeutic class). Whether a competitor can launch at a given time depends on whether it can work around (or wait out) the specific patents listed against Skyla, plus any exclusivity protections. Checking Skyla’s patent-by-patent timeline is the key step. [1]
How to find Skyla’s exact patent(s) quickly
If you want the specific patent numbers and the mapped end dates for Skyla, start with the Skyla entry on DrugPatentWatch.com, then open the “patents” section to see the individual expiration/exclusivity entries. [1]
Sources:
[1] https://www.drugpatentwatch.com/